28 Days of the Hepatitis C Protease Inhibitor VX-950, in Combination With PEG-Interferon-ALFA-2a and Ribavirin, Is Well-Tolerated and Demonstrates Robust Antiviral Effects
Open Access
- 30 September 2006
- journal article
- abstracts
- Published by Elsevier in Gastroenterology
- Vol. 131 (3) , 950-951
- https://doi.org/10.1053/j.gastro.2006.06.100
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: